Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B.

MLA

Rogers, Geoffrey L., et al. “Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B.” Journal of Translational Medicine, vol. 12, Jan. 2014, p. 25. EBSCOhost, https://doi.org/10.1186/1479-5876-12-25.

APA

Rogers, G. L., Martino, A. T., Zolotukhin, I., Ertl, H. C. J., & Herzog, R. W. (2014). Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B. Journal of Translational Medicine, 12, 25. https://doi.org/10.1186/1479-5876-12-25

Chicago

Rogers, Geoffrey L, Ashley T Martino, Irene Zolotukhin, Hildegund C J Ertl, and Roland W Herzog. 2014. “Role of the Vector Genome and Underlying Factor IX Mutation in Immune Responses to AAV Gene Therapy for Hemophilia B.” Journal of Translational Medicine 12 (January): 25. doi:10.1186/1479-5876-12-25.